.Back to listing

Tue, Jan 14

Managing incidental genomic findings in clinical trials

Duke researchers provide commentary on the complexities of incidental findings in clinical genomic trials, arguing that the return of incidental findings to clinical trials participants should be offered via an “opt-in” process and is ultimately essential to promoting justice in clinical trials. Read More